Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 4 | 13 | +0,17 % | ||
| BIOGEN | 1 | 54 | +3,79 % | ||
| ROIVANT SCIENCES | 1 | 3 | -0,27 % | ||
| ANAVEX LIFE SCIENCES | 1 | - | +4,15 % | ||
| ULTRAGENYX | 1 | - | -0,95 % | ||
| AMGEN | - | 27 | +0,06 % | ||
| INCYTE | - | 25 | -0,65 % | ||
| REGENERON PHARMACEUTICALS | - | 22 | -0,27 % | ||
| MONTE ROSA THERAPEUTICS | - | 21 | +3,60 % | ||
| EYEPOINT | - | 20 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03:06 | Biogen Inc.: Biologics License Application for Subcutaneous Formulation of "LEQEMBI" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China | 3 | GlobeNewswire (USA) | ||
| So | MESOBLAST LIMITED: Becoming a substantial holder | - | ASX | ||
| So | Sonntagsausblick Biontech: Analysten erwarten starken Wochenstart - jetzt beachten! | Hebelschein-Spekulant | |||
| So | Quant snapshot: Manulife, KBC, Ambev lead strong buys as Ultragenyx, Atomera lag | 2 | Seeking Alpha | ||
| So | Clinical Trial Win Bolsters Blockbuster Prospects for Roivant Rare Disease Drug Licensed From Pfizer | 27 | MedCity News | ||
| So | ANAVEX LIFE SCIENCES CORP vor nervösem Kursschub | 3 | Maximilian Berger | ||
| Sa | Why Biogen Stock Surged Almost 9% Higher on Friday | 10 | The Motley Fool | ||
| Sa | Illumina-Aktie -10%: Kann man hier günstig einsteigen? | 597 | sharedeals.de | Mit einem Kursverlust von -10% war die Illumina-Aktie am Freitag der große Verlierer im S&P 500. Der Hersteller von Gensequenzierungsmaschinen setzte damit seinen Abwärtstrend der letzten Tage fort.... ► Artikel lesen | |
| Fr | Jyong Biotech ernennt Wei (Vivi) Zhang zur neuen Finanzvorständin | 2 | Investing.com Deutsch | ||
| Fr | $1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today | 16 | Benzinga.com | ||
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 4 | GlobeNewswire (USA) | ||
| Fr | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Jyong Biotech Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Fr | Orchestra BioMed Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Altimmune, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 17 | SEC Filings | ||
| Fr | Pyxis Oncology, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 6 Analysts | 4 | Benzinga.com | ||
| Fr | P/E Ratio Insights for Amgen | 3 | Benzinga.com | ||
| Fr | Ocular Therapeutix, Inc.: Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 8 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.